Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

4.40
+0.05001.15%
Post-market: 4.430.0300+0.68%17:59 EDT
Volume:277.40K
Turnover:1.23M
Market Cap:166.55M
PE:-4.75
High:4.60
Open:4.35
Low:4.29
Close:4.35
52wk High:8.98
52wk Low:3.63
Shares:37.85M
Float Shares:19.33M
Volume Ratio:2.11
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-11.73
PE(LYR):-8.15

Loading ...

Lifecore Biomedical Inc - Product May Generate Commercial Revenue Within 24 Months

THOMSON REUTERS
·
Mar 23

CORRECTION: Lifecore Biomedical Q4 EPS $(0.16) Up From $(0.20) YoY, Sales $35.747M Down From $37.886M YoY

Benzinga Earnings
·
Mar 18

Lifecore price target lowered to $5 from $8.50 at Stephens

TIPRANKS
·
Mar 17

Lifecore Biomedical Raised to Outperform From Market Perform by Barrington Research

Dow Jones
·
Mar 17

Lifecore Stock Sinks As Delayed Launches Push Growth Further Out

Benzinga Earnings
·
Mar 17

Lifecore Biomedical Inc : Barrington Research Raises to Outperform From Market Perform

THOMSON REUTERS
·
Mar 17

Barrington Upgrades Lifecore Biomedical to Outperform From Market Perform, Sets $5.50 Price Target

MT Newswires Live
·
Mar 17

Top Midday Decliners

MT Newswires Live
·
Mar 17

Lifecore Biomedical Q2 EPS $(0.16) Misses $(0.15) Estimate, Sales $35.747M Beat $35.224M Estimate

Benzinga Earnings
·
Mar 16

Lifecore Biomedical Inc - Expects 2026 Revenue $120-$125 Mln; Adj Ebitda $20.5-$25 Mln

THOMSON REUTERS
·
Mar 16

Lifecore Biomedical Inc: Q4 EPS $-0.16

THOMSON REUTERS
·
Mar 16

Lifecore Biomedical Inc - Q4 Revenue $35.7 Mln

THOMSON REUTERS
·
Mar 16

Press Release: Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update

Dow Jones
·
Mar 16

Lifecore Biomedical to participate in KeyBanc Capital Markets Healthcare Virtual Forum

Reuters
·
Mar 11

Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026

GlobeNewswire
·
Mar 10